Skip to content

European Prospective Registry on Anomalous Aortic Origin of the Coronary Arteries

EUROAAOCA Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06089902
Acronym
EUROAAOCA
Enrollment
500
Registered
2023-10-19
Start date
2019-01-01
Completion date
2029-01-01
Last updated
2023-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult Children, Arrhythmia, Congenital Heart Disease, Coronary Artery Anomaly, Diagnosis, Heart Defects, Congenital, Sudden Cardiac Death, Surgical Procedure, Unspecified

Keywords

anomalous, coronary, sudden cardiac death

Brief summary

Anomalous aortic origin of a coronary artery (AAOCA) is a group of rare congenital heart defects with various clinical presentations. The lifetime-risk of an individual living with AAOCA is unknown, and data from multicentre registries are urgently needed to adapt current recommendations and guide optimal patient management. The European Registry for AAOCA (EURO-AAOCA) aims to assess differences with regard to AAOCA management between centres.

Detailed description

EURO AAOCA study database on management for ANOMALOUS AORTIC ORIGIN OF CORONARY ARTERIES. This is a simple Excel database in 8 sections (see below). The patient's identification (ID) should be anonymous, and can be decided by each center; the investigators suggest to enclose Centre ID number (which is communicated by the leading center) and a sequential number or date of birth (dd/mm/yy). If no procedure has been done for the patients , it is required to the PERIPROCEDURAL, SURGICAL DETAILS and POSTPROCEDURAL data sheets (which are outlined in RED). In the PERIPROCEDURAL sheet, the participants may refer either to the surgical or non surgical procedure. Baseline and long term clinical evaluation sections must be completed for all patients. In the database, there are lists of multiple different variables which are summarized in tables enclosed in the section, in which each item corresponds to a number. EURO AAOCA Study DATABASE sections 1. Baseline demo and anatomy: it includes demographic data, and anatomical details for each patient; basic anatomy and course can be selected scrolling an enclosed list; remaining data are requested as yes/no answer 2. Baseline symptoms and indications: it includes symptoms info and indications to surgical/interventional/clinical follow up for each patient; symptoms can be selected scrolling an enclosed list; remaining data are requested as yes/no answer or text; in particular, the participants are required to distinguish between recreational non-competitive sports (2-3/week) and Competitive (\>5 times/week), Reason for diagnosis in asymptomatic patient can be selected scrolling a list. 3. Baseline instrumental: it includes all possible diagnostic methodologies used for first diagnosis; the test is considered abnormal when it is gives diagnosis of AAOCA, and in this case , the participants are required to describe the findings as precise as possible. In particular, for non-surgical patients, the participants are required to provide a date of the first time any instrumental test suspected AAOCA. ECG data can be selected scrolling an enclosed list; remaining data are requested as yes/no answer or text 4. Periprocedural: if the patient has gone to surgical or interventional management, the participants are required to fill this section: data can be selected scrolling an enclosed list; remaining data are requested as yes/no answer or text 5. Surgical details: for surgical patients only, the participants are required to fill this section; data can be selected scrolling an enclosed list; remaining data are requested as yes/no answer or text 6. Post procedural: for surgical or interventional patients only, the participants are required to fill this section; data can be selected scrolling an enclosed list; remaining data are requested as yes/no answer or text 7. Follow up 1: this section must be filled for all patients (surgical/interventional /only medical management) and must be updated every year and sent back to the coordinator every June 15th, so as to check yearly the patients. The Investigators suggest an annual follow up for at least 5 years in a row. Follow up data can be selected scrolling an enclosed list; remaining data are requested as yes/no answer or text. T 8. Follow up Instrumental diagnosis: this section must be filled for all patients (surgical/interventional /only medical management) and must be updated every year and sent back to the coordinator every June 15th, so as to check yearly the patients. The investigators suggest to do this for at least 5 years in a row. Follow up data can be selected scrolling an enclosed list; remaining data are requested as yes/no answer or text

Interventions

PROCEDUREunroofing or other surgery if needed

unroofing of coronary artery

Sponsors

IRCCS Policlinico S. Donato
CollaboratorOTHER
Mitera Children's Hospital, Athens Heart Surgery Institute, Greece
CollaboratorUNKNOWN
Ospedale Civile Ca' Foncello
CollaboratorOTHER
University Hospital, Ghent
CollaboratorOTHER
Guy's and St Thomas' NHS Foundation Trust
CollaboratorOTHER
Azienda Ospedaliera Universitaria Integrata Verona
CollaboratorOTHER
University Medical Center Groningen
CollaboratorOTHER
Hospital Universitario La Paz
CollaboratorOTHER
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
CollaboratorOTHER
Insel Gruppe AG, University Hospital Bern
CollaboratorOTHER
Azienda Ospedaliero-Universitaria di Parma
CollaboratorOTHER
University of Padova
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All patients with a diagnosis of AAOCA (either referred to surgery or to medical follow-up )

Exclusion criteria

* isolated high-coronary take-off (≥ 5mm above sino-tubular junction), anomalous origin of a circumflex from the right coronary artery, anomalous course with a normal origin, and association to major congenital heart disease (i.e. Tetralogy of Fallot, transposition of the great arteries, anomalous origin of a coronary from the pulmonary artery).

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Symptoms at diagnosis and after surgery5 yearsThe study will assess the presence of symptoms (angina, chest pain, distress, sudden cardiac death-SCD, syncope, aborted SCD) at diagnosis, and after eventual surgical repair, to assess incidence of symptoms in patients with this anomaly and effectiveness of surgery in removing symptoms.
Incidence of postoperative adverse events5 yearsThe study will assess the incidence of operative death and adverse events after surgery (in those who undergo surgery).
Incidence of adverse events at follow up5 yearsThe study will assess the incidence of death and adverse events at clinical follow up either in patients who required a surgical repair or in those who did not undergo surgery because of lack of indications.

Secondary

MeasureTime frameDescription
Incidence of any arrhythmias at Follow up5 yearsThe study will assess the incidence of any (mostly ventricular) arrhythmias in all patients, either surgical or non surgical
Rate of return to unrestricted competitive sport5 yearsThe study will assess the rate of return to unrestricted sport and competitive sport activity in all patients, either surgical or non surgical

Countries

Italy, Switzerland

Contacts

Primary ContactMassimo Padalino, MD PhD
massimo.padalino@unipd.it00393408922564
Backup ContactChris Grani, MD PhD
christoph.graeni@insel.ch0041788158858

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026